PLx Pharma Winddown Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PLx Pharma Winddown Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2022.
  • PLx Pharma Winddown Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$8.5M, a 60.7% increase year-over-year.
  • PLx Pharma Winddown Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$27.6M, a 52.2% increase year-over-year.
  • PLx Pharma Winddown Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$46.1M, a 203% decline from 2020.
  • PLx Pharma Winddown Corp. annual Net Income (Loss) Attributable to Parent for 2020 was -$15.2M, a 25.8% increase from 2019.
  • PLx Pharma Winddown Corp. annual Net Income (Loss) Attributable to Parent for 2019 was -$20.5M, a 2387% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$27.6M -$8.5M +$13.1M +60.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$40.7M -$11.9M +$4.65M +28.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-10
Q1 2022 -$45.4M -$10.8M +$755K +6.54% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-10
Q4 2021 -$46.1M $3.56M +$11.5M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 -$57.7M -$21.6M -$18.5M -592% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$39.2M -$16.5M -$10.9M -195% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$28.2M -$11.5M -$13M -871% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$15.2M -$7.98M -$5.98M -299% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$9.23M -$3.13M -$4.83M -284% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.4M -$5.6M +$3.75M +40.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$8.15M $1.5M +$12.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$20.5M -$2M -$4.95M -168% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$15.6M $1.7M +$5.13M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$20.7M -$9.35M -$5.74M -159% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$14.9M -$10.9M -$15.8M -318% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 $896K $2.95M +$10.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$9.93M -$3.43M +$374K +9.86% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$10.3M -$3.6M -$1.37M -61.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$8.94M $4.98M +$6.41M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$15.3M -$7.88M -$11.3M -328% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$4M -$3.8M -$2.72M -251% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$1.28M -$2.24M -$768K -52.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$516K -$1.43M +$4.39M +75.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$4.91M $3.46M +$8.97M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$13.9M -$1.08M +$3.94M +78.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$17.8M -$1.47M +$2.56M +63.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$20.4M -$5.82M -$1.63M -38.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-17
Q4 2015 -$18.7M -$5.5M -$2.23M -68.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-01-20
Q3 2015 -$16.5M -$5.02M -$1.18M -30.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$15.3M -$4.03M -$112K -2.85% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$15.2M -$4.19M -$1.64M -64.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$13.6M -$3.27M -$1.02M -45.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-22
Q3 2014 -$12.6M -$3.84M -$2.85M -288% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$9.71M -$3.92M -$3.56M -979% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$6.15M -$2.54M -$2.14M -526% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$4.01M -$2.25M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 -$991K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$363K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$407K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.